|Mr. Daniel L. Reuvers||Pres, CEO & Director||576.95k||N/A||1963|
|Mr. Brent A. Moen||Chief Financial Officer||402.34k||N/A||1967|
|Ms. Kristie T. Burns||Sr. VP of Marketing & Clinical Affairs||322.27k||N/A||1972|
|Mr. Eric C. Pauls||Sr. VP of Sales||390k||N/A||1975|
|Mr. Jerry A. Sauber||VP of Operations||N/A||N/A||N/A|
|Mr. Peter C. Schaubach||Chief Information Officer||N/A||N/A||N/A|
|Ms. Sunday J. Hoy||VP & Compliance Officer||N/A||N/A||N/A|
|Janelle Strop||Chief Human Resource Officer||N/A||N/A||N/A|
|Mr. Thomas F. O'Donnell Jr., M.D.||Chief Medical Officer & Member of Vascular Strategic Advisory Board||N/A||N/A||N/A|
Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers; and AffloVest, a portable high frequency chest wall oscillation test for the treatment of retained pulmonary secretions such as bronchiectasis, cystic fibrosis, and various neuromuscular disorders. The company was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.
Tactile Systems Technology, Inc.’s ISS governance QualityScore as of 28 January 2023 is 4. The pillar scores are Audit: 5; Board: 3; Shareholder rights: 4; Compensation: 6.